Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment

Core Viewpoint - Royal Philips announced proposed appointments and re-appointments for its Supervisory Board, including the appointment of John DeFord and the re-appointments of Paul Stoffels, Herna Verhagen, and Sanjay Poonen, while Roy Jakobs is proposed for re-appointment as President/CEO [8][11][15]. Group 1: Board Appointments - John DeFord is proposed as a new member of the Supervisory Board, recognized for his extensive experience in the medical device industry and expertise in regulatory affairs and quality systems [9][10]. - Paul Stoffels, Herna Verhagen, and Sanjay Poonen are recommended for re-appointment due to their valuable contributions and strong track records in medical and health technology [12][15]. - Marc Harrison will step down from the Supervisory Board after his second term, having served since 2018 [13][14]. Group 2: Leadership and Strategic Direction - Roy Jakobs is proposed for re-appointment as President/CEO, reflecting the Supervisory Board's confidence in his leadership and the progress made since 2022 [15]. - The continued service of the re-appointed members is expected to strengthen the Supervisory Board as Philips advances its strategic priorities, including innovation and patient safety [12][15]. Group 3: Company Overview - Royal Philips is a leading health technology company focused on improving health and well-being through innovation, with 2025 sales of EUR 18 billion and approximately 64,800 employees [18].